NCT01044745 2023-09-06Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerUniversity of NebraskaPhase 2 Terminated20 enrolled 8 charts
NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts
NCT00427557 2012-05-28Cellular Therapy With Cord Blood CellsM.D. Anderson Cancer CenterPhase 2 Completed31 enrolled 6 charts